Search results :

5-ASA

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: A07EC02

Side effects

Options: Show MedDRA Preferred Terms,   display all 37 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Cramp muscle 66% 10% x x x x x x
Discomfort 66% 10% x x
Throat sore 19% 9% x x x
Eructation postmarketing, 16% 15% x x x x x x
Pain postmarketing, 11% - 23% 1% - 11% x x x x x x x x x
Abdominal bloating 12% 2% x x
Haemorrhoids postmarketing, 11% 0% x x x x
Pharyngitis postmarketing, 11% - 22% 9% - 15% x x x
Asthenia postmarketing, 1% - 20% 4% - 16% x x x x x x x x x x x
Back pain postmarketing, 1.2% - 21% 1% - 11% x x x x x x x x x
Nervousness postmarketing, 6% 2% x x x x x
Arthralgia very rare — 1.1% - 17% 1% - 9% x x x x x x x x x x x x x x x x
Constipation postmarketing, 4% - 13% 1% - 13% x x x x x x x x x x
Body temperature increased postmarketing — 0% - 26% 0% - 13% x x x x x x x x x x x x x x x x
Headache postmarketing — 2% - 53% 0.559% - 49% x x x x x x x x x x x x x x x x x
Hypertonia postmarketing, 4% - 5% 3% x x
Rhinitis postmarketing, 5% - 43% 5% - 36% x x x x x
Tenderness 5% 3% x x
Micturition burning 5% 4% x x
Nasopharyngitis 1.4% - 15% 3% x x x
Rectal disorder 1% - 7% 2% x x x x
Influenza like illness postmarketing, 4% 4% x x
Colitis ulcerative uncommon, 0.8% - 12% x x x x
Diarrhoea postmarketing — 0% - 40% 5% - 49% x x x x x x x x x x x x x x x x x
Rectal tenesmus postmarketing, 6% - 7% 5% x x x x x x
Abdominal pain postmarketing — 1.5% - 66% 10% - 44% x x x x x x x x x x x x x x x x
Chest pain postmarketing — 3% - 8% 2% - 6% x x x x x x x x
Colitis 1.2% - 10% 0% - 8% x x x
Dizziness postmarketing — 0.7% - 15% 2.4% - 8% x x x x x x x x x x x x x x x
Dysmenorrhoea postmarketing, 1% - 5% 2% - 3% x x
Flatulence postmarketing — 0.7% - 50% 2% - 30% x x x x x x x x x x x x
Influenza 0% - 14% 2% - 20% x x x x x x x x
Nausea postmarketing — 1.3% - 47% 3% - 15% x x x x x x x x x x x x x x x x
Sinusitis postmarketing, 0% - 7% 3% - 6% x x x x x x
Sweating postmarketing, 3% 1% x x x x x x
Chills postmarketing, 3% 2% x x x x
Oedema peripheral postmarketing, 3% - 5% 2% - 11% x x x x x x
Myalgia very rare — 3% - 8% 1% - 5% x x x x x x x x x
Nervous system disorder 2% - 3% 0% x x x x x x
Lipase increased 0% - 5% x x
Liver function test abnormal 0.565% - 2.3% 1.12% x
Anxiety postmarketing, 2% - 3% 2% x x x x x x
Arthritis postmarketing, 1% - 2% 0% - 2% x x x x x
Bronchitis postmarketing, 2% - 3% 2% x x x x
Conjunctivitis postmarketing, 2% 0% x x x x x
Fatigue postmarketing, 1% - 28% 8% x x x x x x x x
Arthropathy postmarketing, 2% - 3% 0% x x x x x
Pruritus postmarketing — 0.565% - 10% 0% - 7% x x x x x x x x x x x x x x x
Malaise postmarketing, 1% - 28% 1% - 8% x x x x x x x x x
Enlargement abdomen postmarketing, 2% - 3% 0% x x x x x
Cough increased 0.7% - 12% 1% - 16% x x
Acne 1.2% - 3.5% 0% - 1% x x x x x
Insomnia postmarketing, 1% - 5% 0% - 5% x x x x x x x x
Proctalgia postmarketing, 1.8% - 10% 0% - 3% x x x x x
Dyspepsia rare, 0.8% - 9% 1% - 9% x x x x x x x
Rash postmarketing — 1% - 23% 0% - 4% x x x x x x x x x x x x x x x x x x
Amblyopia 1% - 2% 0%
Epistaxis 1% - 2% 0%
Lacrimal disorder 1% - 2% 0%
Prostatic disorder 1% - 2% 0%
Vomiting postmarketing — 0.6% - 6% 2% - 7% x x x x x x x x x x x x x
Abdominal pain upper postmarketing, 1.2% - 5% 3% x x x
Asthma 0% - 2% 0%
Cystitis 0% - 2% 0%
Hypertension 1% x
Vaginal inflammation 0% - 2% 0% x
Alanine aminotransferase increased 0.565% - 1.12% 0% x
Drug ineffective uncommon x
Crohns disease aggravated uncommon x
Cough very rare — 0% - 5% x x x x x x
Abdominal cramps postmarketing x x x
Abdominal distension postmarketing, 1.3% x x x x x x
Agranulocytosis very rare, postmarketing x x x x x x x x x x x x x x x
Alopecia very rare — 0% - 7% 0% x x x x x
Alveolitis allergic postmarketing x x x x x
Anaphylactic shock postmarketing
Anaemia postmarketing x x x x x x x x x x x
Aplastic anaemia very rare, postmarketing x x x x x x x x x x x x x x x
Angina pectoris postmarketing x
Angioedema postmarketing x
Anorexia postmarketing x x x x x x x x
Rheumatoid arthritis postmarketing x x x x
Atrial fibrillation postmarketing x
Mental disorder postmarketing x x
Breast feeding postmarketing x
Neck pain postmarketing x x x x x x
Cholecystitis postmarketing x x x x x x
Coma postmarketing x
Infection postmarketing, 3.2% - 9% 3% x x x x x x
Confusional state postmarketing x x x x x
Connective tissue disorder postmarketing x x
Libido decreased postmarketing x x x x
Delirium postmarketing x
Depression postmarketing x x x x
Dysgeusia postmarketing x x x x x x
Dysuria postmarketing, 1% - 2% 1% x x x x x
Ear disorder postmarketing x x x x
Ear pain postmarketing x x x x x
Eating disorder postmarketing x
Oedema postmarketing x x x x x x x x
Eosinophilia postmarketing, uncommon x x x x x x x x x x x x
Epididymitis postmarketing x x x x x
Erythema nodosum postmarketing x x x x x x x x x x
Eye disorder postmarketing x
Cardiac flutter postmarketing x
Gastritis postmarketing x x x x x x
Gastroenteritis postmarketing, 2% - 5% 1% x x x x x x
Gastrointestinal disorder postmarketing x x x x x x x
Gastrointestinal haemorrhage postmarketing, 8% - 10% 8% x x x x x x x x x x
Glossodynia postmarketing x
Gout postmarketing x x x x x
Guillain-Barre syndrome postmarketing x x x x x
Cardiac disorder postmarketing x x x x x x
Haematochezia postmarketing x x
Haematuria postmarketing, 0% - 3% 1% x x x x x x x x
Hepatitis very rare, postmarketing x x x x x x x x x x x x x x
Hepatitis toxic postmarketing x
Hyperaesthesia postmarketing x x x x x
Hyperhidrosis postmarketing x
Hypocalcaemia postmarketing x
Hypotension postmarketing x x
Immune system disorder postmarketing x x
Jaundice postmarketing x x x x x x x x
Jaundice cholestatic postmarketing x x x x x x x x
Nephropathy postmarketing x x x x
Renal failure acute postmarketing x x x
Renal failure chronic postmarketing x x x
Leukopenia very rare, postmarketing x x x x x x x x x x x
Liver disorder postmarketing x
Malabsorption postmarketing x
Mediastinal disorder postmarketing x x x x x x
Menorrhagia postmarketing x x x x x x x x
Musculoskeletal pain postmarketing x
Myelitis transverse postmarketing x x x x x x x
Myocarditis postmarketing, rare x x x x x x x x x x x x
Nephritis interstitial postmarketing x x x x x x x x x x x
Lipoid nephrosis postmarketing x x x x x
Oligospermia very rare, postmarketing x x x x x x x
Palpitations postmarketing x x x
Pancreatitis postmarketing 0% x x x x x x x x x x x x x x x x x x x
Paraesthesia postmarketing, 0% - 5% 5% x x x x x x x x x
Peptic ulcer perforation postmarketing x x x x x x
Pericardial effusion postmarketing x x x
Pericarditis postmarketing, rare 0% x x x x x x x x x x x x x x x
Pericarditis constrictive postmarketing x
Neuropathy peripheral very rare, postmarketing x x x x x x x x x x
Pleurisy postmarketing x x x x x x
Pneumonia aspiration postmarketing x
Anal pruritus postmarketing x
Psoriasis postmarketing x x x x x x x
Pulmonary eosinophilia very rare, postmarketing x x x x
Pyoderma postmarketing x
Renal failure very rare, postmarketing x x x x x x x x
Reye's syndrome postmarketing x
Muscle spasms postmarketing x
Steatorrhoea postmarketing x
Stevens-Johnson syndrome postmarketing
Stomatitis postmarketing x x x x
Sinus tachycardia postmarketing x
Thrombocytopenia very rare, postmarketing x x x x x x x x x x x x x x
Thrombosis postmarketing x
Tinnitus postmarketing x x x x x x
Tremor postmarketing x x x x x x x
Erythema postmarketing x x
Pollakiuria postmarketing x x x x x x x x
Urticaria postmarketing — 0% - 2% 1% x x x x x x x x x x x x x x
Vasodilation postmarketing x x x x x x x
Vertigo postmarketing x x x x x x
Weight decreased postmarketing x x x
Dry mouth postmarketing, 1% - 2% 0% x x x x x
Acute febrile neutrophilic dermatosis postmarketing x
Hepatic failure postmarketing x x x x x x x x x x
Micturition urgency postmarketing x x x x
Burning sensation postmarketing x
Mood swings postmarketing x x x x x x
Rash pustular postmarketing x
Pyoderma gangrenosum postmarketing x x x x x x
Mouth ulceration postmarketing x x x x x x x x
Migraine postmarketing x x x x x
Blood urea increased postmarketing x x
Diarrhoea haemorrhagic postmarketing x x x x x x x
Tongue discolouration postmarketing x
Tongue oedema postmarketing x
Kidney fibrosis postmarketing x
Hypomagnesaemia postmarketing x
Lactic dehydrogenase activity increased postmarketing x x x x x
Hepatocellular injury postmarketing x x x x x x
Hepatic necrosis postmarketing x x x x x x x x
Skin necrosis postmarketing x
Eye pain postmarketing x x x x x x
Phosphatase alkaline increased postmarketing x x x x x x x
Aspartate aminotransferase increased postmarketing x x x x x
Skin discolouration postmarketing x x
Dry skin postmarketing x x x x x x x x
Interstitial pneumonia very rare, postmarketing x x x x x x x x
Rectal discharge postmarketing x x
Increased appetite postmarketing x x x x x
Abdominal discomfort postmarketing x
Rash erythematous postmarketing x x x
Upset stomach postmarketing x
Faeces discoloured postmarketing x x
Hepatotoxicity postmarketing x x x x x x x
Condition aggravated postmarketing, uncommon x x
Dyschezia postmarketing x x
Frequent bowel movements postmarketing x
Mucous stools postmarketing x
Rectal haemorrhage postmarketing, 2% - 4% 5% x x x x x x x x x x
Eye swelling postmarketing x
Blood bilirubin increased postmarketing x x x x x
Vision blurred postmarketing x x x x x x
Exacerbation of asthma postmarketing x x x x x
Defaecation urgency postmarketing x x x
Stiffness postmarketing x
Lymphadenopathy postmarketing x x x x x
Rash generalised postmarketing x
Chromaturia postmarketing x
Face oedema postmarketing x x x x x x
Anorectal disorder postmarketing x
Gastrointestinal pain postmarketing x x
Ear congestion postmarketing x
Blood creatinine abnormal postmarketing x
Rectal cramps postmarketing x
Lupus-like syndrome postmarketing x x x x x x x x x
Anal discomfort postmarketing x
Medication residue postmarketing x x
Rhinorrhoea postmarketing x
Lichenoid keratosis postmarketing x
Drug fever very rare, postmarketing x x x x x x x x x x
Parosmia postmarketing x
Eosinophilic pneumonia very rare, postmarketing x x x x x x x x x
Anorectal discomfort postmarketing x
Somnolence postmarketing, 0% - 2% 3% x x x x x x x x x
Feeling hot postmarketing x
Dyspnoea very rare, postmarketing x x x x x x x
Blood disorder very rare, postmarketing x x
Neutropenia very rare, postmarketing x x x x x x
Lung infiltration very rare, postmarketing x x x x x x
Pancreatitis acute very rare x x x
Bronchospasm very rare x x x
Cholestasis very rare x x
Hypersensitivity very rare x x x x x x x x x x x
Lung disorder very rare, 0% - 3% 0% x
Nephrotic syndrome very rare x x x x x x
Pancytopenia very rare x x x x x x x
Pneumonia very rare x x x x x
Hepatitis cholestatic very rare x x x
Bone marrow depression very rare x x
Chronic interstitial nephritis very rare x x x x
Lupus erythematosus very rare x x x
Alveolitis very rare x
Pancolitis very rare x x
Allergic exanthema very rare x
Renal impairment very rare x x x x
Adenovirus infection x
Albuminuria x x x
Amenorrhoea x x
Blister x
Bone disorder x x x
Breast disorder x
Obliterative bronchiolitis x x
Oral candidiasis x x x
Vaginal moniliasis
Cholangitis sclerosing x
Cholelithiasis
Deafness
Dysphagia x x x
Dermatitis atopic x
Duodenal ulcer x x x
Ecchymosis x x x
Eczema x x x
Faecal incontinence x x x
Haemorrhage x
Hirsutism x
Hypomenorrhoea x x
Orthostatic hypotension x
Infertility x x
Intestinal obstruction x
Cramps of lower extremities x x x
Lethargy x x x
Leukocytosis x x
Lichen planus x x
Systemic lupus erythematosus x x
Breast pain x x x
Melaena x x
Metrorrhagia x x
Myelitis
Nail disorder x x x
Nephritis x x
Pleural effusion x x
Proteinuria x
Prurigo x
Rectal polyp x
Scotoma x
Shock x
Syncope x
Tachycardia x x
Thirst x x x
Upper respiratory tract infection x x
Urinary tract infection x x
Micturition disorder x
Urinary tract disorder x x x x
Angiopathy
Weight increased x
Hamman-Rich syndrome x x x
Amylase increased x x x x
Creatinine renal clearance decreased x x
Red blood cell sedimentation rate increased x
Gamma-glutamyltransferase increased x x x
Oesophageal ulcer x x x
Unspecified disorder of skin and subcutaneous tissue x x x x x
Interstitial lung disease x
Body mass index decreased x
Decreased appetite x
Abdominal pain lower x
Disorientation x x x
Ache x x x
Abnormal dreams x
Blood creatinine increased x
Urine abnormality
Back distress x x x
Hepatic enzyme increased x x x x x
Lung fibrosis interstitial x x
Hepatobiliary disease x x x x x
Dry eye x
Photosensitivity x x x
Platelet count decreased x
Gastrointestinal symptom NOS x
Transaminases increased x
Neuropathy x
Serum amylase increased x
Urine color abnormal x x
Discomfort rectal x x
Nephrotoxicity x x x
Bilirubin total increased x
Haematocrit decreased x
Thrombocytosis x x x x
Infestation NOS x
Blood and lymphatic system disorders x x
Ear and labyrinth disorders x
Administration site reaction x
Sperm count decreased x
Local reaction x x
Pharyngolaryngeal pain x x
Alopecia reversible x
Hepatic impairment x
Blood methaemoglobin present x
Pleuropericarditis x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

MESALAMINE / CANASA

Side effects:10
Source:FDA

MESALAMINE

Side effects:15
Source:FDA Structured Product Label

MESALAZINE / MESASAL

Side effects:19
Source:Health Canada

MESALAZINE / SALOFALK (R) 5-ASA SUPPOSITORIES - 500MG

Side effects:34
Source:Health Canada

MESALAMINE / LIALDA

Side effects:34
Source:FDA

Mesalamine

Side effects:41
Source:FDA Structured Product Label

MESALAMINE

Side effects:50
Source:FDA Structured Product Label

mesalazine / Pentasa, Suppository

Side effects:59
Source:Medsafe

MESALAMINE

Side effects:69
Source:FDA Structured Product Label

MESALAMINE

Side effects:85
Source:FDA Structured Product Label

MESALAMINE

Side effects:90
Source:FDA Structured Product Label

MESALAMINE

Side effects:93
Source:FDA Structured Product Label

MESALAMINE

Side effects:110
Source:FDA Structured Product Label

MESALAZINE / SALOFALK (R) 2GM/60GM RECTAL SUSPENSION

Side effects:116
Source:Health Canada

MESALAZINE / PENTASA EXTENDED-RELEASE TABLETS 500MG

Side effects:120
Source:Health Canada

MESALAMINE

Side effects:122
Source:FDA Structured Product Label

MESALAMINE / ASACOL HD

Side effects:124
Source:FDA

mesalamine

Side effects:126
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label